47,485 results on '"CANCER prevention"'
Search Results
2. Program of Health Behaviour Against to Cancer (PHeBAC) (PHeBAC)
- Author
-
Habibe ÖZÇELİK, Lecturer Dr
- Published
- 2024
3. Personalised Health Recommendations to the General Population Through an Integrated AI Guided (AIDA)
- Author
-
Tania Fleitas Kanonnikoff, MD, PhD
- Published
- 2024
4. PROFAST Intervention in Precursor Multiple Myeloma (PROFAST)
- Author
-
National Cancer Institute (NCI) and Catherine Marinac, PhD, Principal Investigator
- Published
- 2024
5. Strategies to decrease inequalities in cancer therapeutics, care and prevention: Proceedings on a conference organized by the Pontifical Academy of Sciences and the European Academy of Cancer Sciences, Vatican City, February 23-24, 2023.
- Author
-
Ringborg, Ulrik, von Braun, Joachim, Celis, Julio, Baumann, Michael, Berns, Anton, Eggermont, Alexander, Heard, Edith, Heitor, Manuel, Chandy, Mammen, Chen, Chien-Jen, Costa, Alberto, De Lorenzo, Francesco, De Robertis, Edward, Dubee, Frederick, Ernberg, Ingemar, Gabriel, Mariya, Helland, Åslaug, Henrique, Rui, Jönsson, Bengt, Kallioniemi, Olli, Korbel, Jan, Krause, Mechthild, Lowy, Douglas, Michielin, Olivier, Nagy, Peter, Oberst, Simon, Paglia, Vincenzo, Parker, M, Ryan, Kevin, Sawyers, Charles, Schüz, Joachim, Silkaitis, Katherine, Solary, Eric, Thomas, David, Turkson, Peter, Weiderpass, Elisabete, and Yang, Huanming
- Subjects
cancer prevention ,cancer therapeutics/care ,healthcare ,inequalities ,science policy ,translational cancer research ,Humans ,Vatican City ,Neoplasms ,Translational Research ,Biomedical ,Delivery of Health Care ,Precision Medicine - Abstract
Analyses of inequalities related to prevention and cancer therapeutics/care show disparities between countries with different economic standing, and within countries with high Gross Domestic Product. The development of basic technological and biological research provides clinical and prevention opportunities that make their implementation into healthcare systems more complex, mainly due to the growth of Personalized/Precision Cancer Medicine (PCM). Initiatives like the USA-Cancer Moonshot and the EU-Mission on Cancer and Europes Beating Cancer Plan are initiated to boost cancer prevention and therapeutics/care innovation and to mitigate present inequalities. The conference organized by the Pontifical Academy of Sciences in collaboration with the European Academy of Cancer Sciences discussed the inequality problem, dependent on the economic status of a country, the increasing demands for infrastructure supportive of innovative research and its implementation in healthcare and prevention programs. Establishing translational research defined as a coherent cancer research continuum is still a challenge. Research has to cover the entire continuum from basic to outcomes research for clinical and prevention modalities. Comprehensive Cancer Centres (CCCs) are of critical importance for integrating research innovations to preclinical and clinical research, as for ensuring state-of-the-art patient care within healthcare systems. International collaborative networks between CCCs are necessary to reach the critical mass of infrastructures and patients for PCM research, and for introducing prevention modalities and new treatments effectively. Outcomes and health economics research are required to assess the cost-effectiveness of new interventions, currently a missing element in the research portfolio. Data sharing and critical mass are essential for innovative research to develop PCM. Despite advances in cancer research, cancer incidence and prevalence is growing. Making cancer research infrastructures accessible for all patients, considering the increasing inequalities, requires science policy actions incentivizing research aimed at prevention and cancer therapeutics/care with an increased focus on patients needs and cost-effective healthcare.
- Published
- 2024
6. Cocaine use and head and neck cancer risk: A pooled analysis in the International Head and Neck Cancer Epidemiology Consortium
- Author
-
Zhang, Mingyan, Chen, Chu, Li, Guojun, Koric, Alzina, Lee, Yuan‐Chin Amy, Morgenstern, Hal, Schwartz, Stephen M, Sturgis, Erich M, Boffetta, Paolo, Hashibe, Mia, and Zhang, Zuo‐Feng
- Subjects
Pharmacology and Pharmaceutical Sciences ,Biomedical and Clinical Sciences ,Cancer ,Tobacco Smoke and Health ,Tobacco ,Dental/Oral and Craniofacial Disease ,Rare Diseases ,Drug Abuse (NIDA only) ,Substance Misuse ,Good Health and Well Being ,Humans ,Risk Factors ,Smoking ,Head and Neck Neoplasms ,Alcohol Drinking ,Case-Control Studies ,Cocaine ,cancer prevention ,cocaine inhalation ,drug use ,head and neck cancer ,Biochemistry and Cell Biology ,Oncology and Carcinogenesis ,Oncology and carcinogenesis - Abstract
BackgroundCocaine is an illegal recreational drug used worldwide, yet little is known about whether cocaine inhalation (smoking/snorting) increases the risk of head and neck cancer (HNC).MethodsThe analyses were conducted by pooling data from three case-control studies with 1639 cases and 2506 controls from the International Head and Neck Cancer Epidemiology Consortium. Epidemiologic data, including cocaine use histories, were obtained in face-to-face interviews. Odds ratios (ORs) and corresponding 95% confidence intervals (CIs) were estimated using hierarchical logistic regression models.ResultsControlling for cumulative tobacco and alcohol use, we observed a weak positive association between cocaine use and HNC (ORever vs. never = 1.35, 95% CI: 0.96, 1.90). In stratified analysis, while we did not detect associations among never tobacco or alcohol users due to the limited sample size, the association with cocaine use was observed among tobacco users and alcohol drinkers. ORs for ever and high cumulative use (>18 times) versus never use were 1.40 (95% CI: 0.98, 2.00) and 1.66 (95% CI: 1.03, 2.69) among tobacco users, and 1.34 (95% CI: 0.93, 1.92) and 1.59 (95% CI: 1.00, 2.51) among alcohol drinkers, respectively.ConclusionIn this pooled analysis, we observed a weak positive association between cocaine inhalation and HNC risk. Our findings provide preliminary evidence of the potential carcinogenic effect of cocaine on HNC. Because of study limitations, including limited number of cocaine users, confounding, and heterogeneity across studies, future investigations will require larger studies with more detailed information on cocaine use history.
- Published
- 2024
7. Firefighters Preventing Cancer Online Training Program
- Author
-
Canadian Association of Fire Chiefs, Laval University, and Patrick J. McGrath, Principle Investigator
- Published
- 2024
8. Evaluation of Text or Animation-based Narrative and Non-narrative Interventions to Enhance Cancer Literacy: a Pilot Study (CLARO) (CLARO)
- Author
-
University of Music, Drama, and Media Hannover
- Published
- 2024
9. Cancer Prevention Clinical Decision Support (CP-CDS)
- Published
- 2024
10. Getting Ahead for Cancer Control
- Published
- 2024
11. Unraveling cancer progression pathways and phytochemical therapeutic strategies for its management.
- Author
-
Sharma, Vikas, Chaudhary, Anis Ahmad, Bawari, Sweta, Gupta, Saurabh, Mishra, Richa, Khan, Salah-Ud-Din, Ali, Mohamed A. M., Shahid, Mohammad, Srivastava, Saurabh, Verma, Devvrat, Gupta, Arti, Kumar, Sanjay, and Kumar, Sandeep
- Abstract
Cancer prevention is currently envisioned as a molecular-based approach to prevent carcinogenesis in pre-cancerous stages, i.e., dysplasia and carcinoma in situ. Cancer is the second-leading cause of mortality worldwide, and a more than 61% increase is expected by 2040. A detailed exploration of cancer progression pathways, including the NF-κβ signaling pathway, Wnt-B catenin signaling pathway, JAκ-STAT pathway, TNF-α-mediated pathway, MAPκ/mTOR pathway, and apoptotic and angiogenic pathways and effector molecules involved in cancer development, has been discussed in the manuscript. Critical evaluation of these effector molecules through molecular approaches using phytomolecules can intersect cancer formation and its metastasis. Manipulation of effector molecules liκe NF-κβ, SOCS, β-catenin, BAX, BAκ, VEGF, STAT, Bcl2, p53, caspases, and CDκs has played an important role in inhibiting tumor growth and its spread. Plant-derived secondarymetabolites obtained fromnatural sources have been extensively studied for their cancer-preventing potential in the last few decades. Eugenol, anethole, capsaicin, sanguinarine, EGCG, 6-gingerol, and resveratrol are some examples of such interesting lead molecules and are mentioned in the manuscript. This worκ is an attempt to put forward a comprehensive approach to understanding cancer progression pathways and their management using effector herbal molecules. The role of different plant metabolites and their chronic toxicity profiling in modulating cancer development pathways has also been highlighted. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
12. Applying cognitive walkthrough methodology to improve the usability of an equity-focused implementation strategy.
- Author
-
Aschbrenner, Kelly A., Haines, Emily R., Kruse, Gina R., Olugbenga, Ayotola O., Thomas, Annette N., Khan, Tanveer, Martinez, Stephanie, Emmons, Karen M., and Bartels, Stephen J.
- Subjects
HEALTH equity ,CANCER prevention ,SOCIAL determinants of health ,MEDICAL screening ,ELECTRONIC health records - Abstract
Background: Our research team partnered with primary care and quality improvement staff in Federally Qualified Community Health Centers (CHCs) to develop Partnered and Equity Data-Driven Implementation (PEDDI) to promote equitable implementation of evidence-based interventions. The current study used a human-centered design methodology to evaluate the usability of PEDDI and generate redesign solutions to address usability issues in the context of a cancer screening intervention. Methods: We applied the Cognitive Walkthrough for Implementation Strategies (CWIS), a pragmatic assessment method with steps that include group testing with end users to identify and prioritize usability problems. We conducted three facilitated 60-min CWIS sessions with end users (N = 7) from four CHCs that included scenarios and related tasks for implementing a colorectal cancer (CRC) screening intervention. Participants rated the likelihood of completing each task and identified usability issues and generated ideas for redesign solutions during audio-recorded CWIS sessions. Participants completed a pre-post survey of PEDDI usability. Our research team used consensus coding to synthesize usability problems and redesign solutions from transcribed CWIS sessions. Results: Usability ratings (scale 0–100: higher scores indicating higher usability) of PEDDI averaged 66.3 (SD = 12.4) prior to the CWIS sessions. Scores averaged 77.8 (SD = 9.1) following the three CWIS sessions improving usability ratings from "marginal acceptability" to "acceptable". Ten usability problems were identified across four PEDDI tasks, comprised of 2–3 types of usability problems per task. CWIS participants suggested redesign solutions that included making data fields for social determinants of health and key background variables for identifying health equity targets mandatory in the electronic health record and using asynchronous communication tools to elicit ideas from staff for adaptations. Conclusions: Usability ratings indicated PEDDI was in the acceptable range following CWIS sessions. Staff identified usability problems and redesign solutions that provide direction for future improvements in PEDDI. In addition, this study highlights opportunities to use the CWIS methodology to address inequities in the implementation of cancer screening and other clinical innovations in resource-constrained healthcare settings. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
13. Anticancer applications of phytochemicals in gastric cancer: Effects and molecular mechanism.
- Author
-
Zhaofeng Liang, Yumeng Xu, Yue Zhang, Xinyi Zhang, Jiajia Song, Hui Qian, and Jianhua Jin
- Subjects
HELICOBACTER pylori infections ,INHIBITION of cellular proliferation ,STOMACH cancer ,CANCER prevention ,CELL migration - Abstract
Gastric cancer (GC) is the fourth most common malignant cancer and is a lifethreatening disease worldwide. Phytochemicals have been shown to be a rational, safe, non-toxic, and very promising approach to the prevention and treatment of cancer. It has been found that phytochemicals have protective effects against GC through inhibiting cell proliferation, inducing apoptosis and autophagy, suppressing cell invasion and migration, anti-angiogenesis, inhibit Helicobacter pylori infection, regulating the microenvironment. In recent years, the role of phytochemicals in the occurrence, development, drug resistance and prognosis of GC has attracted more and more attention. In order to better understand the relationship between phytochemicals and gastric cancer, we briefly summarize the roles and functions of phytochemicals in GC tumorigenesis, development and prognosis. This review will probably help guide the public to prevent the occurrence and development of GC through phytochemicals, and develop functional foods or drugs for the prevention and treatment of gastric cancer. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
14. A systematic review of interventions to promote human papillomavirus (HPV) vaccination in Africa.
- Author
-
Olaoye, O. and Macdonald, S.
- Subjects
- *
IMMUNIZATION , *MEDICAL information storage & retrieval systems , *EDUCATIONAL outcomes , *CINAHL database , *VACCINATION , *HUMAN papillomavirus vaccines , *SYSTEMATIC reviews , *MEDLINE , *ATTITUDE (Psychology) , *QUALITY assurance , *HEALTH promotion , *PSYCHOLOGY information storage & retrieval systems - Abstract
We conducted a systematic review to assess the scope and effectiveness of interventions to improve human papilloma virus (HPV) vaccination in Africa from 2006 to 2021. Systematic review. Four databases (Medline, Embase, CINAHL and PsycINFO) were searched for articles published between 2006 and 2021. Articles were screened and included based on eligibility criteria using DistillerSR (Version 2.35). Data were extracted and reported using a narrative synthesis. A quality assessment was also conducted for each study using validated quality appraisal tools. Out of 7603 articles identified by a systematic search, 18 articles met the inclusion criteria. Included studies comprised impact evaluation and cross-sectional studies published between 2012 and 2021 and conducted in eight African countries namely: Nigeria, Cameroon, South Africa, Kenya, Tanzania, Zambia, Mali, and Malawi. Study quality ranged from high to low quality. Interventions comprised fifteen educational and three multicomponent interventions. Out of thirteen impact evaluation studies (all educational interventions), twelve studies were effective in increasing HPV vaccine uptake and/or improving participants' knowledge, attitudes, and perceptions about the vaccine. Across five cross-sectional studies (two educational and three multicomponent interventions), HPV vaccine uptake rates ranged from 34% to 93.3%, with a consensus on safety and effectiveness in 67.9%–90.3% of participants post-intervention. Educational and multicomponent interventions have been implemented to improve HPV vaccination in Africa. While educational interventions have proven effective at improving HPV vaccine uptake, a more diverse range of interventions with robust impact evaluation study designs are needed to strengthen the available evidence and improve vaccine uptake. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
15. Reproducibility of colposcopy quality indicators—A survey among members of the European Federation for Colposcopy.
- Author
-
Randrup, Tina Hovgaard, Leeson, Simon, Ciavattini, Andrea, Eldib, Ahmed, Grigore, Mihaela, van Haaften‐de Jong, Anne‐Marie, Jariene, Kristina, Kesic, Vesna, Koiss, Róbert, Kotaniemi‐Talonen, Laura, Quaas, Jens, Raud, Terje, Zodzika, Jana, and Hammer, Anne
- Subjects
- *
MEDICAL quality control , *CERVICAL intraepithelial neoplasia , *EUROPEAN integration , *COLPOSCOPY , *CANCER prevention - Abstract
Introduction: Colposcopy is an important part of the diagnostic work‐up of women with an abnormal cervical screening test as it is used to guide the collection of biopsies. Although quality assurance has been used in the evaluation of screening programs, not much is known about quality indicators for the diagnostics and treatment of screen‐positive women. Therefore, the European Federation for Colposcopy developed quality indicators aiming to support colposcopy practice across Europe. We performed a survey of colposcopy cases to determine if the quality indicators are understandable, relevant, and reproducible. Material and Methods: We conducted a survey among all members of the European Federation for Colposcopy Quality and Standards Group from November 2022 to March 2023. Members were asked to collect information on a total of 17 quality indicators for 50 women who had been newly referred for colposcopy due to an abnormal screening test between January 1, 2020 to December 31, 2021. Results were reported descriptively. Results: We included data on 609 cases from 12 members across Europe. The majority of the quality indicators were either achieved or within reach of the agreed standard, often due to few countries with outlying data. One quality indicator had very low performance, although stratified results indicated that two countries had different clinical management of the patient type thereby skewing the results. In addition, discrepancies between the number of cases included in each quality indicator raised concerns regarding potential misunderstanding of the quality indicator and its objective. Conclusions: Quality indicators on colposcopy must be understandable to those collecting data, highlighting the importance of validating quality indicators before data collection. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
16. Chemoprotective and immunomodulatory potential of Lactobacillus reuteri against cadmium chloride-induced breast cancer in mice.
- Author
-
Sajjad, Ayesha, Ali, Shaukat, Mumtaz, Samaira, Summer, Muhammad, Farooq, Muhammad Adeel, and Hassan, Ali
- Subjects
- *
LACTOBACILLUS reuteri , *BREAST cancer , *CADMIUM , *CADMIUM chloride , *CANCER prevention - Abstract
The current study aimed to investigate the role of probiotic Lactobacillus reuteri for the treatment and prevention of breast cancer. Breast cancer was induced by using Cadmium Chloride (Cd) (2 mg/kg) in group II. Tamoxifen was administered to group III. Group IV was treated with Lactobacillus reuteri. Group V was treated with Cd for one month and divided into three subgroups including VA, VB, and VC which were treated with tamoxifen, Lactobacillus reuteri , and tamoxifen + Lactobacillus reuteri , respectively. Significantly higher levels of TNF-α (40.9 ± 4.2 pg/mL), IL-6 (28.0 ± 1.5 pg/mL), IL-10 (60.2 ± 2.0 pg/mL), IFN-γ (60.2 ± 2.0 pg/mL), ALAT (167.2 ± 6.2 U/l), ASAT (451.6 ± 13.9 U/l), and MDA (553.8 ± 19.6 U/l) was observed in Cd group. In comparison, significantly lower levels of TNF-α (18.0 ± 1.1 pg/mL), IL-6 (9.4 ± 0.4 pg/mL), IL-10 (20.8 ± 1.1 pg/mL), IFN-γ (20.8 ± 1.1 pg/mL), ALAT (85.2 ± 3.6 U/l), ASAT (185 ± 6.9 U/l), and MDA (246.0 ± 7.5 U/l) were observed in group Cd + Tam + LR. Liver histopathology of the Cd group showed hemorrhage and ductal aberrations. However, mild inflammation and healthier branched ducts were observed in treatment groups. Furthermore, the renal control group showed normal glomerular tufts, chronic inflammation from the Cd group, and relatively healthier glomerulus with mild inflammation in treatment groups. Hence, the preventive and anticancerous role of probiotic Lactobacillus reuteri is endorsed by the findings of the current study. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
17. Association of GLP-1 Receptor Agonists and Hepatocellular Carcinoma Incidence and Hepatic Decompensation in Patients With Type 2 Diabetes.
- Author
-
Wang, Lindsey, Berger, Nathan A., Kaelber, David C., and Xu, Rong
- Abstract
Hepatocellular carcinoma (HCC) is a leading cause of cancer death. HCC is preventable with about 70% of HCC attributable to modifiable risk factors. Glucagon-like peptide-1 receptor agonists (GLP-1RAs), Food and Drug Administration–approved medications for treating type 2 diabetes mellitus (T2DM), have pleiotropic effects on counteracting risk factors for HCC. Here we evaluate the association of GLP-1RAs with incident HCC risk in a real-world population. This retrospective cohort included 1,890,020 patients with a diagnosis of T2DM who were prescribed GLP-1RAs or other non-GLP-1RA anti-diabetes medications and had no prior diagnosis of HCC. Incident (first-time) diagnosis of HCC and hepatic decompensating events during a 5-year follow-up was compared between cohorts of patients prescribed GLP-1 RAs vs other anti-diabetes medications. Time-to-first-event analysis was performed using Kaplan-Meier survival analysis with hazard ratio and 95% confidence interval calculated. GLP-1RAs were associated with a lower risk of incident HCC with hazard ratio of 0.20 [0.14–0.31], 0.39 [0.21–0.69], 0.63 [0.26–1.50] compared with insulin, sulfonylureas, and metformin, respectively. GLP-1RAs were associated with a significantly lower risk of hepatic decompensation compared with 6 other anti-diabetes medications. Reduced risks were observed in patients without and with different stages of fatty liver diseases, with more profound effects in patients without liver diseases. Similar findings were observed in patients with and without obesity and alcohol or tobacco use disorders. GLP-1RA combination therapies were associated with decreased risk for HCC and hepatic decompensations compared with monotherapies. GLP-1RAs were associated with a reduced risk of incident HCC and hepatic decompensation compared with other anti-diabetes medications in patients with T2DM. These findings provide supporting evidence for future studies to investigate the underlying mechanisms and their clinical use. Glucagon-like peptide-1 receptor agonists alone and in combination with other anti-diabetes medications were associated with a reduced risk of hepatocellular carcinoma incidence and hepatic decompensation events in patients with type 2 diabetes. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
18. It's not just about the sun, it's about a living: Rural older farmers’ experience of skin cancer risk and prevention.
- Author
-
Yu, Shih‐Yin, Hirsch, Anne, Zaslavsky, Oleg, and Cochrane, Barbara B.
- Subjects
- *
ACCESS to primary care , *HEALTH Belief Model , *CONSCIOUSNESS raising , *SKIN cancer , *CANCER prevention - Abstract
Objective Design and sample Results Conclusions To understand rural older farmers’ perspectives and attitudes toward skin cancer risk and prevention.This study used a grounded theory approach and semi‐structured interviews with 12 rural older farmers (farm owners, farmworkers ages 50 years or older) in Washington. Participants’ perspectives were explored relative to Health Belief Model constructs. Inductive and deductive analyses were used to generate relevant themes. COREQ guidelines were followed.The findings fit well and extended the Health Belief Model, which was used to arrange key themes identified in relation to skin cancer risk and prevention, specifically participants’ perceived barriers to accessing primary care and protection when outdoors, perceived benefits of sun‐protective behaviors, perceived hereditary susceptibility to skin cancer, perceived severity of the increased skin cancer risk, and cues to action for skin checks. A new construct of hope was identified to emphasize the importance of establishing emotional, instrumental, and informational support systems for promoting skin cancer prevention. Participants also indicated their hope of raising awareness of skin cancer prevention among all ages.Findings highlighted the importance of integrating skin cancer prevention services for rural older farmers and across the lifespan. Public health approaches are needed to enhance the awareness of and access to preventive care in these underserved populations. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
19. Picrasidine S Induces cGAS‐Mediated Cellular Immune Response as a Novel Vaccine Adjuvant.
- Author
-
Ding, Xiaofan, Sun, Mengxue, Guo, Fusheng, Qian, Xinmin, Yuan, Haoyu, Lou, Wenjiao, Wang, Qixuan, Lei, Xiaoguang, and Zeng, Wenwen
- Subjects
- *
VACCINE effectiveness , *IMMUNE response , *INTERFERON receptors , *TYPE I interferons , *VIRAL vaccines , *CANCER vaccines , *SMALL molecules - Abstract
New adjuvants that trigger cellular immune responses are urgently needed for the effective development of cancer and virus vaccines. Motivated by recent discoveries that show activation of type I interferon (IFN‐I) signaling boosts T cell immunity, this study proposes that targeting this pathway can be a strategic approach to identify novel vaccine adjuvants. Consequently, a comprehensive chemical screening of 6,800 small molecules is performed, which results in the discovery of the natural compound picrasidine S (PS) as an IFN‐I inducer. Further analysis reveals that PS acts as a powerful adjuvant, significantly enhancing both humoral and cellular immune responses. At the molecular level, PS initiates the activation of the cGAS‐IFN‐I pathway, leading to an enhanced T cell response. PS vaccination notably increases the population of CD8+ central memory (TCM)‐like cells and boosts the CD8+ T cell‐mediated anti‐tumor immune response. Thus, this study identifies PS as a promising candidate for developing vaccine adjuvants in cancer prevention. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
20. Reducing information avoidance: The effectiveness of humour, cute animals and coping messages.
- Author
-
Orom, Heather, Allard, Natasha C., Hay, Jennifer L., Kiviniemi, Marc T., Waters, Erika A., and McQueen, Amy
- Subjects
- *
INFORMATION-seeking behavior , *FOOT care , *COLORECTAL cancer , *CANCER prevention , *LOGISTIC regression analysis - Abstract
Objectives Design Methods Results Conclusions Guided by the hedonic surplus/mood‐as‐resource hypotheses, we sought to identify message components that prevent health information avoidance by inducing hedonic psychological states.Two experimental studies.Participants, age 45–75, recruited from the online survey platform, Prolific (Study 1 N = 288, Study 2 N = 505), completed a survey of their colorectal cancer (CRC) information avoidance tendency and demographics. They were reinvited to participate in a study where they were randomized to view one of four types of images: humorous comics, cute animals, coping messages or streetscapes images (control condition). To assess CRC information avoidance behaviour after viewing the stimuli, participants choose whether to be directed to a website to complete a CRC risk calculator (Study 1), or whether to view a CRC information video or a video about foot care (Study 2). Using logistic regression, we regressed each outcome variable on interactions between self‐reported CRC information avoidance tendency and experimental condition. We then used the PROCESS macro to test if mood mediated these interaction effects.In Study 1, to the degree participants reported CRC information avoidance tendency, viewing humorous comics compared to control images increased their odds of choosing to view the risk calculator (OR = 5.26, p = .02). The same was true in Study 2 for choosing to watch the video about CRC vs. foot care (OR = 2.42, p = .04). Effects were not mediated through mood and there were no effects for the cute animals or coping messages.Using humour at the outset of a health message may increase reach to people who otherwise avoid CRC or other health messaging. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
21. Policy brief Belgian EBCP Mirror Group patient and citizen engagement.
- Author
-
Van Hoof, Wannes and Schittecatte, Gabrielle
- Subjects
PATIENT participation ,SOCIAL networks ,CANCER prevention ,DATA quality ,MIRRORS - Abstract
Rights, preferences, needs and expectations of patients and citizens can only be respected and addressed if they are well understood. As such, a continuous, systematic and formalised dialogue between patients, citizens and policy makers is required to ensure ethical and socially appropriate cancer prevention, diagnostics, treatment and care. Relying on donations and project-based funding is not a sustainable way to ensure patient involvement and representativeness in policy. Patient organizations need long term, structural support to fulfil their role as patient representatives and support network in order to deliver the best possible service and to play their role as a professional representative of their disease-specific community. Inequalities can only be tackled if they are properly identified. This requires the definition of appropriate determinants fit for (inter)national comparison and extension and linkage of good quality data registries for cancer that allow the monitoring these inequalities. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
22. Unveiling the multifaceted realm of human papillomavirus: a comprehensive exploration of biology, interactions, and advances in cancer management.
- Author
-
Meng Wu, Hui Huang, Ying Tang, Xuze Ren, Xinrui Jiang, Man Tian, and Wei Li
- Subjects
HUMAN papillomavirus ,DNA viruses ,HUMAN papillomavirus vaccines ,CARCINOGENESIS ,MEDICAL screening - Abstract
Human Papillomavirus (HPV), an extensive family of DNA viruses, manifests as a persistent global health challenge. Persistent HPV infection is now firmly established as a significant aetiological factor for a spectrum of malignancies. In this review, we examine the latest insights into HPV biology and its intricate relationship with the host. We delve into the complex dynamics of co-infections involving HPV alongside other viruses, such as HIV, EBV, and HSV, as well as the burgeoning role of the microbiome in cancer development. We also explore recent advancements in understanding the specific contributions of HPV in the development of various cancers, encompassing cancers of the anogenital region, head and neck, as well as breast, lung, and prostate. Moreover, we focus on the current preventive strategies, including vaccination and screening methods, and therapeutic interventions that range from traditional approaches like surgery and chemotherapy to emerging modalities such as targeted therapies and immunotherapies. Additionally, we provide a forward-looking view on the future directions of HPV research, highlighting potential areas of exploration to further our understanding and management of HPV and its associated cancers. Collectively, this review is positioned to deepen readers' understanding of HPV biology and its complex interplay with cancer biology. It presents innovative strategies for the prevention, management, and therapeutic intervention of HPV-associated malignancies. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
23. Validity of self-reported sleep duration in the Cancer Prevention Study– 3.
- Author
-
Donzella, Sidney M., Masters, Matthew, Phipps, Amanda I., Patel, Alpa V., and Zhong, Charlie
- Subjects
- *
SLEEP duration , *NIGHT work , *CANCER prevention , *RANK correlation (Statistics) , *TEST reliability - Abstract
Purpose: We examined the one-year test re-test reliability and validity criterion of survey-assessed sleep duration collected from two separate questions. Methods: The Activity Validation Sub Study included 751 participants of the Cancer Prevention Study-3 study to further investigate rest/activity cycles. Sleep duration was collected using three methods: survey, Daysimeter device, and sleep diary. Survey-assessed sleep duration was collected using 2 different questions, each with different response options (categorical and continuous). Selected participants (n = 170) were asked to wear a Daysimeter device for seven consecutive days for two non-consecutive quarters. Participants were excluded from the current study due to incomplete/implausible survey or device data or reported working night shift. We calculated reliability of pre- and post-survey sleep duration for both survey question using Spearman correlation. We used the method of triads to estimate the validity coefficient (VC) between the three sleep duration measurements in the present study and the "true" latent sleep duration measure, and bootstrapping methods to calculate the 95% confidence intervals (95%CI). Results: Of 119 participants included in the study (52.10% male), test-retest correlation showed strong and moderate correlations for sleep duration collected continuously and categorically, respectively. The VC for survey-assessed continuous sleep duration was 0.82 (95%CI 0.71, 0.90) for weekday and 0.68 (95%CI 0.46, 0.83) for weekend. Performance of the VC was slightly weaker for survey-assessed categorical sleep duration (weekday VC = 0.57 95%CI 0.42, 0.71; weekend VC = 0.47 95%CI 0.29, 0.62). Conclusion: The two survey-assessed sleep duration questions used in the AVSS and CPS-3 cohorts are valid approximations of sleep duration. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
24. Enhancing food access in a comprehensive cancer center area of influence through local partner capacity building.
- Author
-
Loomba, Preena, Raber, Margaret R., Aquino, Mayra, Rincon, Nikki, Rumfield, Lori, Basen‐Engquist, Karen M., and Rechis, Ruth
- Subjects
- *
ARCHITECTURAL details , *FOOD security , *CAPACITY building , *CANCER prevention , *LOCAL foods - Abstract
Background: Food insecurity, an economic and social condition of limited food access, is associated with poor diet quality—a risk factor for several common cancers. The University of Texas MD Anderson Cancer Center supports healthy food access through community‐led evidence translation by actively partnering with community‐based organizations (CBOs). These partnerships aim to enhance the capacity of food assistance CBOs to effectively implement evidence‐based food insecurity mitigation programs in the cancer center's area of influence. Methods: This case study aims to describe the cancer center's model for local food access capacity building and detail operationalization in the context of a whole‐community cancer prevention effort (Be Well Baytown) in Baytown, Texas. Results: Elements central to the capacity building model include (i) assessment of baseline needs and capacity, (ii) empowering a community champion within a relevant CBO, (iii) mapping inter‐sectoral community partnerships, collaborations, and linkages, and (iv) leveraging systems, connections, and resources to provide an enabling environment for overall food access systems growth. Through this process, Be Well Baytown enhanced the capacity of a local food pantry leading to increases in total reach, pounds of food distributed, and number of food distribution events in collaboration with intersectoral partners from 2018 to 2023. Conclusion: This case study highlights the model's implementation as a co‐benefit community partnership strategy to maximize the impact of food security programs integrated with comprehensive cancer center prevention efforts. The purpose of this case study is to summarize learning from supporting food assistance CBOs to effectively implement evidence‐based food insecurity mitigation programs and to better understand how to optimize use of community‐driven food security programs aligned to Comprehensive Cancer Center's (CCC) community outreach and engagement (COE) efforts. The case study demonstrates a successful community partnership strategy integrating food security programs into comprehensive cancer prevention efforts that improved the capacity of a local food pantry, resulted in expanded reach, increased food distribution, and more collaborations with partners from 2018 to 2023 offering a model for other CCCs. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
25. The association between physical activity and risk of gastric cancer; an umbrella review.
- Author
-
Maleki, Mahsa, Fatehi, Vahid, and Mohammadzadeh, Zeinab
- Subjects
- *
PHYSICAL activity , *STOMACH cancer , *DISEASE risk factors , *CANCER prevention , *UMBRELLAS - Abstract
Introduction: Gastric cancer (GC), as a highly lethal malignancy, is the fourth most common malignancy and the second leading cause of cancer-related death worldwide. This study is an umbrella review of systematic reviews and meta-analyses to present an overview of the extent and reliability of the claimed association between physical activity and the likelihood of developing or dying from GC. Method: This study was conducted following the Joanna Brigs Institute (JBI)'s methods for conducting umbrella reviews. A systematic search was performed in PubMed, Scopus, Web of Science, and ProQuest databases until July, 2024 with predefined keywords. Two independent authors assessed the Risk of Bias in included studies using the JBI critical appraisal tool for the assessment of the quality of systematic reviews and disagreements between the authors were resolved through discussion or the opinion of another author. Result: Five systematic reviews were included in this analysis, offering a more comprehensive understanding of the inverse relationship between physical activity and gastric cancer risk. Compared to previous studies, this review provides stronger evidence that moderate-to-high levels of physical activity significantly reduce the overall risk of developing gastric cancer. Conclusion: While a link between physical activity and reduced cancer risk is promising, further research is crucial to unravel the specific mechanisms at play and to quantify the impact of increased activity levels on cancer prevention. Based on the findings of this study, physical activity is found to be associated with a decreased risk of GC; however, the limitation of the evidence suggested a need for future studies on this topic. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
26. Challenges associated with follow-up care after implementation of an HPV screen-and-treat program with ablative therapy for cervical cancer prevention.
- Author
-
Morse, Rachel M., Brown, Joanna, Ríos López, E. Jennifer, Prieto, Bryn A., Kohler-Smith, Anna, Gonzales Díaz, Karina, Figueredo Escudero, Magaly, Lenin del Cuadro, Daniel, Vásquez del Aguila, Giannina, Daza Grandez, Henrry, Meza‑Sánchez, Graciela, Tracy, J. Kathleen, Gravitt, Patti E., Paz‑Soldan, Valerie A., Carhuaza, Iris, Carrillo Jara, Lita E., Carmen del Caruhapoma, María, Del Carpio-Morgan, Meda, Garcia Satalay, Esther Y., and Gilman, Sarah D.
- Subjects
- *
HEALTH services accessibility , *CERVICAL cancer , *HUMAN papillomavirus , *CANCER prevention , *PATIENT monitoring - Abstract
Background: Cervical cancer is a preventable cancer; however, decreasing its prevalence requires early detection and treatment strategies that reduce rates of loss to follow-up. This study explores factors associated with loss to follow-up among HPV-positive women after implementation of a new HPV-based screen-and-treat approach for cervical cancer prevention in Iquitos, Peru. Methods: We conducted semi-structured interviews with "obstetras" (i.e., midwives) (n = 15) working in cervical cancer prevention and women (n = 24) who were recorded as lost to follow-up after positive HPV results. We used the Health Care Access Barriers Model to guide analyses. We utilized manifest content analysis to describe barriers to follow-up according to the obstetras and thematic analysis to report themes from the women's perspectives. We also report the steps and time taken to contact women. Results: We found an incomplete and fragmented patient monitoring system. This incomplete system, in conjunction with challenges in contacting some of the women, led to structural barriers for the obstetras when attempting to deliver positive results. Women in this study expressed a desire to receive treatment, however, faced cognitive barriers including a lack of understanding about HPV results and treatment procedures, fear or anxiety about HPV or treatment, and confusion about the follow-up process. Women also reported having important work matters as a barrier and reported frequently using natural medicine. Reported financial barriers were minimal. Conclusion: This study highlights the barriers to follow-up after implementation of a primary-level HPV-based screen-and-treat approach. While some barriers that have previously been associated with loss to follow-up were not as prominently observed in this study (e.g., financial), we emphasize the need for screen-and-treat programs to focus on strategies that can address incomplete registry systems, structural challenges in results delivery, cognitive barriers in understanding results and treatment, and work-related barriers. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
27. Experiences of a group of indigenous women from the Colombian Amazon with cervical cancer prevention screening. Qualitative study in the context of participatory research to reduce inequalities.
- Author
-
Sarmiento-Medina, María Inés, Velásquez-Jiménez, Claudia Marcela, and Ortiz-Hernández, Natalia
- Subjects
- *
MEDICAL personnel , *INDIGENOUS women , *HEALTH equity , *INDIGENOUS peoples of South America , *CANCER prevention - Abstract
ObjectivesDesignResultsConclusionDespite cervical cancer (CC) being a preventable disease, its incidence remains high in marginalized communities due to inequalities that restrict access to health services. This article investigates the experiences, perceptions, and attitudes regarding the screening of indigenous women in a region of the Colombian Amazon during a cervical cancer prevention initiative facilitated by community participation.Qualitative study based on interviews conducted with women and indigenous leaders from Paujil reserve. They participated in research focused on cervical cancer prevention, which employed a methodology of collaboration between academia and communities aimed at enhancing women’s health and reducing inequalities in access to healthcare services. The analysis utilized a deductive and inductive approach.Five main themes were addressed: ‘Barriers within health services’; ‘Individual and cultural constraints’; ‘Motivations and facilitators’; ‘Positive experiences within the research framework’; and ‘Suggestions for encouraging women's participation.’ Challenges related to appointment scheduling and result delivery were frequently cited as obstacles to access. Misinformation, feelings of shame, fear, and distrust towards health services played significant roles in the reluctance to undergo screening. Factors such as support from family and community networks, respectful treatment, ease of scheduling appointments, the presence of female healthcare professionals, and involvement of leaders fluent in indigenous languages were identified as positive facilitators of screening acceptance.Understanding the factors that influence access to screening is crucial for reducing inequalities in service delivery for indigenous women. The involvement of trained leaders who can identify these factors and motivate women can have a positive impact on the acceptance and guidance of cervical cancer prevention programs. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
28. Implementation and Evaluation of a Multi-level, Place-Based Tobacco Prevention and Control Program at a Minority-Serving Institution in Texas.
- Author
-
Love, Brad, Coffman, Rosemary, Ghosh, Charulata, Cofer, Jennifer, Hurst, Alex N., Oestman, Katherine, Aquino, Mayra, Kriss, Lauren, Shah, Mansi, Dermid, Gerold, Raber, Margaret, Hawk, Ernest, Walsh Jr., Michael T., and Rechis, Ruth
- Abstract
Multi-level, place-based interventions have proven effective at promoting a range of health behaviors, including tobacco control and discouraging the uptake of tobacco products. This paper describes the implementation and impact of a 3-year, multi-level tobacco prevention and control program at a community-college minority-serving institution (MSI) on the Texas Gulf Coast within the context of a broader multi-sector, cross-functional health coalition. The intervention studied included a tobacco-free policy, a large-scale communication campaign highlighting parts of the intervention and prevention and cessation resources. The intervention was bolstered by the support of a community-led Steering Committee and tobacco control experts. Results from the first 3 years of implementation show that tobacco-free policies were largely supported by community members, awareness of the policy increased over time, and tobacco prevention and cessation resources were successfully embedded into campus norms. This multi-component approach shows how a community college was able to effectively reach students and staff on their campus to increase awareness of both the campus tobacco-free policy and the availability of tobacco prevention and cessation resources. Additionally, it also offers lessons for future tobacco prevention and control work in higher education. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
29. 2' Life-changing minutes: impact evaluation of a novel health promotion format on cancer prevention.
- Author
-
Ribeiro, Nuno, Carvalho, Luís, Oliveira, Pedro, and Marcos, Nuno T
- Subjects
- *
TUMOR risk factors , *CROSS-sectional method , *RISK assessment , *HABIT , *ENVIRONMENTAL monitoring , *T-test (Statistics) , *RESEARCH funding , *EARLY detection of cancer , *HEALTH , *LOGISTIC regression analysis , *BEHAVIOR , *INFORMATION resources , *TELEVISION , *DESCRIPTIVE statistics , *DISEASES , *ODDS ratio , *ALTERNATIVE medicine , *STORYTELLING , *RESEARCH , *COMMUNICATION , *HEALTH promotion , *HEALTH education , *TUMORS , *MOTION pictures , *SOCIODEMOGRAPHIC factors , *COMPARATIVE studies , *CONFIDENCE intervals , *DATA analysis software , *PREVENTIVE health services , *REGRESSION analysis ,TUMOR prevention - Abstract
Cancer is one of the most important societal challenges in the world, with over 23 million new cases/year and 10 million deaths/year, that will only be properly tackled with a stronger focus on prevention. This calls for an informed population, aware of risk factors and willing to adopt preventive behaviors and early cancer screenings. For that purpose, 2' Life-changing minutes was created, the first ever televised Entertainment-Education series on cancer prevention. This study aims to evaluate the impact of 2' Life-changing minutes , a novel E-E format for cancer prevention, on knowledge gains and behavior changes. Two complementary studies were performed involving a total of 1314 participants: a test-screening (TS) study targeting potential viewers of the series, and a natural-screening (NS) study targeting those that spontaneously watched the series on television. We found (i) very high levels of appreciation and narrative engagement, and also willingness to see more episodes; (ii) statistically significant knowledge gains, ranging from 17% to 44%, on all four topics tested; (iii) evidence of effective behavior change. Regression analysis showed that narrative engagement was the best predictor of behavior change [NS: odds ratio (OR) = 3.38, 95% confidence interval (CI) = 1.70–6.74, p = 0.001; TS: OR = 2.05, 95% CI = 1.13–0.371, p = 0.018]. This study demonstrates the series' real impact and serves as a proof-of-concept for a novel strategy of cancer prevention that is based around compelling health narratives, rather than information or data, to engage viewers, increase knowledge and induce behavior change. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
30. The Role of Inositols in Endocrine and Neuroendocrine Tumors.
- Author
-
Mormando, Marilda, Puliani, Giulia, Bianchini, Marta, Lauretta, Rosa, and Appetecchia, Marialuisa
- Subjects
- *
NEUROENDOCRINE tumors , *THYROID cancer , *CANCER prevention , *INOSITOL , *OXIDATIVE stress - Abstract
Inositols have demonstrated a role in cancer prevention and treatment in many kinds of neoplasms. Their molecular mechanisms vary from the regulation of survival and proliferative pathways to the modulation of immunity and oxidative stress. The dysregulation of many pathways and mechanisms regulated by inositols has been demonstrated in endocrine and neuroendocrine tumors but the role of inositol supplementation in this context has not been clarified. The aim of this review is to summarize the molecular basis of the possible role of inositols in endocrine and neuroendocrine tumors, proposing it as an adjuvant therapy. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
31. Modified plant‐derived exosomes: Precision medicine in cancer treatment.
- Author
-
Maitra, Swastika, Sarkar, Subham, and Dhara, Bikram
- Subjects
- *
INDIVIDUALIZED medicine , *EXOSOMES , *CANCER treatment , *EXTRACELLULAR vesicles , *CANCER prevention - Abstract
Plant‐derived exosomes (PDEs) are extracellular vesicles (EVs) occurring naturally,which have propitious applications in the development of cost‐effective and fruitful cancer therapy with minimum aftereffects and ramifications. Recent advancements in research based on PDEs demonstrate their extraordinary advantages in cancer therapy. The components of PDEs exhibit accomplished cancer prevention activity and having insignificant or negligible toxicity. The conventional methods to deliver drugs to the target have various problems, several of which can be solved by using PDEs for drug delivery. The main constituents of PDEs are proteins, lipids, DNA and RNA. PDEs are believed to revolutionize cancer therapy due to their magnificent attributes, but only a few clinical trials on PDEs are in progress. The mechanisms and regulations by which PDEs execute anticancer properties are yet not completely understood. Hence, research are conducted worldwide to understand the mechanisms of action of cancer antagonist PDEs more comprehensively and perspicuously. Modified PDEs have prospect in evolution of precision medicine which can bring a new dimension in the treatment of cancer. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
32. Influence of Political Ideology on Colorectal Cancer Screening Among Adults in the United States.
- Author
-
Bilalaga, Mariah Malak, Atarere, Joseph, Vasireddy, Ramya, Gaddipati, Greeshma N., Mensah, Boniface, and Kanth, Priyanka
- Subjects
- *
PREVENTIVE health services , *MODERATES (Political science) , *EARLY detection of cancer , *POLITICAL doctrines , *AGE differences - Abstract
Background: Political ideologies have emerged as one of the risk factors driving healthcare decisions, including colorectal cancer screening in US adults. Previous links between conservative viewpoints and lower awareness of preventive health services have been established. We aimed to evaluate how differences in political ideology affect CRC screening practices using a nationally representative sample of US adults. Methods: Using data from the 2020 Health Information National Trends Survey (HINTS), we compared compliance with CRC screening guidelines between conservative, moderate, and liberal political groups. Survey-weighted multivariable logistic regression models were employed to ascertain the relationship between political ideology and CRC screening. Results: Of the 3368 respondents, 71.0% (95% CI: 67.8, 74.0) were screened for CRC. A total of 1026 (30.5%) were liberal, 1148 (34.1%) were moderate, and 1194 (35.4%) were conservative. Out of the conservatives (78.8%) were non-Hispanic Whites compared to moderates (61.4%) and liberals (64.0%). There was no significant difference in age, level of education, or income group by political ideology. In adjusted models, there was no significant difference in CRC screening by political ideology. Conclusion: Contrary to previous ties, we found no significant differences in compliance with CRC screening guidelines among these groups, concluding that CRC screening remains a significant health concern for all individuals, irrespective of political ideologies. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
33. Targeted Screening for Cancer: Learnings and Applicability to Melanoma: A Scoping Review.
- Author
-
Zheng, Lejie, Smit, Amelia K., Cust, Anne E., and Janda, Monika
- Subjects
- *
MEDICAL screening , *EARLY detection of cancer , *CANCER prevention , *OVARIAN cancer , *BREAST cancer - Abstract
This scoping review aims to systematically gather evidence from personalized cancer-screening studies across various cancers, summarize key components and outcomes, and provide implications for a future personalized melanoma-screening strategy. Peer-reviewed articles and clinical trial databases were searched for, with restrictions on language and publication date. Sixteen distinct studies were identified and included in this review. The studies' results were synthesized according to key components, including risk assessment, risk thresholds, screening pathways, and primary outcomes of interest. Studies most frequently reported about breast cancers (n = 7), followed by colorectal (n = 5), prostate (n = 2), lung (n = 1), and ovarian cancers (n = 1). The identified screening programs were evaluated predominately in Europe (n = 6) and North America (n = 4). The studies employed multiple different risk assessment tools, screening schedules, and outcome measurements, with few consistent approaches identified across the studies. The benefit–harm assessment of each proposed personalized screening program indicated that the majority were feasible and effective. The establishment of a personalized screening program is complex, but results of the reviewed studies indicate that it is feasible, can improve participation rates, and screening outcomes. While the review primarily examines screening programs for cancers other than melanoma, the insights can be used to inform the development of a personalized melanoma screening strategy. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
34. Alliums as Potential Antioxidants and Anticancer Agents.
- Author
-
Iwar, Kanivalan, Ochar, Kingsley, Seo, Yun Am, Ha, Bo-Keun, and Kim, Seong-Hoon
- Subjects
- *
ALLIUM , *LEEK , *ORGANOSULFUR compounds , *PSEUDOPOTENTIAL method , *CANCER prevention , *GARLIC - Abstract
The genus Allium plants, including onions, garlic, leeks, chives, and shallots, have long been recognized for their potential health benefits, particularly in oxidative and cancer prevention. Among them, onions and garlic have been extensively studied, unveiling promising biological activities that are indicative of their potential as potent antioxidant and anticancer agents. Research has revealed a rich repository of bioactive compounds in Allium species, highlighting their antioxidative properties and diverse mechanisms that target cancer cells. Compounds such as allicin, flavonoids, and organosulfur compounds (OSCs) exhibit notable antioxidant and anticancer properties, affecting apoptosis induction, cell cycle arrest, and the inhibition of tumor proliferation. Moreover, their antioxidant and anti-inflammatory attributes enhance their potential in cancer therapy. Studies exploring other Allium species beyond onions and garlic have revealed similar biological activities, suggesting a broad spectrum of natural products that could serve as promising candidates for developing novel anticancer treatments. Understanding the multifaceted potential of Allium plants will pave the way for innovative strategies in oxidative and cancer treatment and prevention, offering new avenues for pharmaceutical research and dietary interventions. Therefore, in this review, we compile an extensive analysis of the diversity of various Allium species, emphasizing their remarkable potential as effective agents. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
35. Methodological examination of the 2018 World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) Score.
- Author
-
Shams-White, Marissa M, Thompson, E Christi, Carroll, Raymond J, and Reedy, Jill
- Subjects
- *
TUMOR risk factors , *RISK assessment , *CLINICAL medicine research , *BODY weight , *CONVENIENCE foods , *MEAT , *LONGITUDINAL method , *ENDOWMENT of research , *PLANT-based diet , *TUMORS , *PHYSICAL activity , *OLD age ,MORTALITY risk factors ,RESEARCH evaluation - Abstract
The objective of this study was to examine the impact of methodological changes to the 2018 World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) Score on associations with risk for all-cause mortality, cancer mortality, and cancer risk jointly among older adults in the National Institutes of Health (NIH)-AARP Diet and Health Study. Weights were incorporated for each score component; a continuous point scale was developed in place of the score's fully discrete cut points; and cut-point values were changed for physical activity and red meat based on evidence-based recommendations. Exploratory aims also examined the impact of separating components with more than one subcomponent and whether all components were necessary to retain within this population utilizing a penalized scoring approach. Findings suggested weighting the original 2018 WCRF/AICR Score improved its predictive performance in association with all-cause mortality and provided more precise estimates in relation to cancer risk and mortality outcomes. The importance of healthy weight, physical activity, and plant-based foods in relation to cancer and overall mortality risk were highlighted in this population of older adults. Further studies are needed to better understand the consistency and generalizability of these findings across other populations. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
36. The Co‐Production, Pilot and Qualitative Evaluation of a Cancer Prevention Programme With High‐Risk Women Delivered on Group Walks by Cancer Champions: Shoulder to Shoulder, Walk and Talk.
- Author
-
Hanson, Sarah and Hardeman, Wendy
- Subjects
- *
TUMOR risk factors , *PATIENT education , *MOTIVATIONAL interviewing , *RESEARCH funding , *QUALITATIVE research , *FOCUS groups , *EVALUATION of human services programs , *EARLY detection of cancer , *PILOT projects , *HELP-seeking behavior , *BEHAVIOR , *WALKING , *TRUST , *HEALTH promotion , *WOMEN'S health , *GROUP process ,TUMOR prevention - Abstract
Objectives: Women in the criminal justice system and women who have been subject to domestic abuse are at high risk of cancer but underrepresented in health promotion research. We aimed to co‐produce, pilot and evaluate a health promoting programme delivered on group walks. Design: A programme co‐produced by women, based on motivational interviewing, created the opportunity for supportive conversations about cancer prevention. Methods: Programme development in two workshops with women with lived experience using authentic vignettes to prompt help‐seeking conversations. A small pilot and a qualitative evaluation was done using framework analysis. Results: The programme appeared acceptable to women and the walk leaders. Women felt included and found it a safe space for sensitive conversations. They appeared empowered and more confident to seek help. Walk leaders expressed confidence in delivering this informal programme, which used prompts rather than delivering didactic training. Conclusion: Cancer prevention for high‐risk groups can be delivered in a personalised and novel way by creating informal opportunities for supportive conversations about cancer prevention. Careful co‐production of the programme of walks with women, using scenarios and quotes that were authentic vignettes, ensured that these came directly from the women's lived experience and enabled women to talk about change. Our findings indicate that this approach was practical, relevant and acceptable to them with some evidence of women feeling empowered to make informed decisions about their health. We recommend that future cancer prevention programmes for underrepresented groups take an asset‐based approach by utilising pre‐existing community organisations to increase reach and sustainability. Patient and Public Involvement: Women with lived experience co‐designed and tested the programme. Provisional findings were fed back to the women and the women's organisation that partnered with this research. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
37. From sweat to hope: The role of exercise‐induced extracellular vesicles in cancer prevention and treatment.
- Author
-
Llorente, Alicia, Brokāne, Agnese, Mlynska, Agata, Puurand, Marju, Sagini, Krizia, Folkmane, Signe, Hjorth, Marit, Martin‐Gracia, Beatriz, Romero, Silvana, Skorinkina, Diana, Čampa, Mārtiņš, Cešeiko, Rūdolfs, Romanchikova, Nadezhda, Kļaviņa, Aija, Käämbre, Tuuli, and Linē, Aija
- Subjects
- *
EXTRACELLULAR vesicles , *CANCER prevention , *OVERALL survival , *BLOOD cells , *SKELETAL muscle - Abstract
The benefits of regular physical exercise on cancer prevention, as well as reducing fatigue, treatment side effects and recurrence, and improving quality of life and overall survival of cancer patients, are increasingly recognised. Initial studies showed that the concentration of extracellular vesicles (EVs) increases during physical activity and that EVs carry biologically active cargo. These EVs are released by blood cells, skeletal muscle and other organs involved in exercise, thus suggesting that EVs may mediate tissue crosstalk during exercise. This possibility triggered a great interest in the study of the roles of EVs in systemic adaptation to exercise and in their potential applications in the prevention and treatment of various diseases, including cancer. This review presents studies exploring the concentration and molecular cargo of EVs released during exercise. Furthermore, we discuss putative stimuli that may trigger EV release from various cell types, the biological functions and the impact of exercise‐induced EVs on cancer development and progression. Understanding the interplay between exercise, EVs, and cancer biology may offer insights into novel therapeutic strategies and preventive measures for cancer. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
38. Identifying associations between sample characteristics, symptoms, and self‐efficacy differences in adult patients with rare tumors of the central nervous system who participated in a novel web‐based natural history study.
- Author
-
Acquaye‐Mallory, Alvina, Vera, Elizabeth, Choi, Anna, Wall, Kathleen, Gilbert, Mark R., and Armstrong, Terri S.
- Subjects
- *
SPINAL cord tumors , *SYMPTOM burden , *NATURAL history , *CENTRAL nervous system , *BRAIN tumors ,CENTRAL nervous system tumors - Abstract
Objective: High self‐efficacy is associated with improved self‐care and reduced symptoms in cancer patients but has not been fully interrogated in adults with central nervous system (CNS) cancers. We aimed to identify the relationship between self‐efficacy levels in managing emotions (SEMEM) and social interactions (SEMSI) by examining sample characteristics and symptom burden. Methods: Sample characteristics and patient‐reported outcome (PRO) measures addressing self‐efficacy (PROMIS SEMEM & SEMSI) and symptom burden (MDASI BT or SP) were collected in a novel web‐based study of 158 adult patients diagnosed with rare CNS tumors. Results: The sample was predominantly female (73%), diagnosed with an ependymoma (66%), and had a median age of 45 (19–75). Low SEMEM was associated with a longer duration of symptoms before surgery (r = −0.26) and female gender (92%) among brain tumor (BT) participants and in spinal cord tumors (SCT), those with lower education (r = 0.29). Reporting low SEMSI was associated with being married (42%), lower education (r = 0.22), and a prolonged time with symptoms before surgery (r = 0.29) in those with BTs, with no associations identified in SCT. More severe mood‐related interference (including mood, enjoyment of life, and relationship with others) was associated with lower SEMEM among both locations (r = −0.61 brain, r = −0.28 spine) and SEMSI in BT participants (r = −0.54). Conclusions: Low self‐efficacy was linked to a prolonged time between symptom onset and initial surgery, education, gender, and marital status and was associated with higher mood‐related interference. Understanding characteristics associated with low self‐efficacy underscores a need for future studies to tailor interventions that enhance self‐efficacy. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
39. A case for the study of native extracellular vesicles.
- Author
-
Nambiar, Dhanya, Quynh-Thu Le, and Pucci, Ferdinando
- Subjects
B cell lymphoma ,EXTRACELLULAR vesicles ,CELL communication ,EARLY detection of cancer ,CANCER prevention - Abstract
Threemain areas of research revolve around extracellular vesicles (EVs): their use as early detection diagnostics for cancer prevention, engineering of EVs or other enveloped viral-like particles for therapeutic purposes and to understand how EVs impact biological processes. When investigating the biology of EVs, it is important to consider strategies able to track and alter EVs directly in vivo, as theyare releasedby donor cells. This can be achieved by suitable engineering of EV donor cells, either before implantation or directly in vivo. Here, wemake a case for the study of native EVs, that is, EVs released by cells living within a tissue. Novel genetic approaches to detect intercellular communications mediated by native EVs and profile recipient cells are discussed. The use of Rab35 dominant negative mutant is proposed for functional in vivo studies on the roles of native EVs. Ultimately, investigations on native EVs will tremendously advance our understanding of EV biology and open novel opportunities for therapy and prevention. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
40. A sensitive electrochemical detection of carotenoid in food samples as an effective pigment in prevention of cancer cells.
- Author
-
Tao, Yu
- Subjects
MOLYBDENUM oxides ,GRAPHENE oxide ,CANCER prevention ,DETECTION limit ,STANDARD deviations ,MOLYBDENUM disulfide - Abstract
This work offers a novel method for the sensitive electrochemical detection of carotenoids in dietary samples, namely β-carotene (β-CA). A reduced-graphene oxide and molybdenum disulfide (MoS
2 /rGO) composite was created, and the electrode was modified using the β-carotene oxidase (β-Ox) enzyme. The special properties of both MoS2 and rGO, such as their large surface area, strong conductivity, and electrocatalytic potential, are responsible for the sensor's improved performance. The selectivity and sensitivity of the sensor towards β-CA are further improved by the β-Ox enzyme, which is well-known for its capacity to oxidize β-CA. With a limit of detection set at 0.2 nM, the sensor demonstrated dual linear detection ranges from 50 nM to 33 µM. The sensor showed good recovery between 94.00% and 99.20%, with a relative standard deviation between 3.25% and 4.56%. The strong selectivity, stability, and reproducibility of the β-Ox/MoS2 /rGO/GCE biosensor, combined with its successful detection of β-CA in prepared tomato samples and human blood serum samples, make it a perfect platform for an extensive range of other biosensor applications. This creative method offers a fresh perspective for further study in this area. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
41. In Silico Investigations and Potential Approaches of Tectona grandis via Targeting MMP-9 for Triple Negative Breast Cancer.
- Author
-
Permana, Sofy, Hanum, Halida A., Azizah, Maghfira R., Ilmiyah, Silvi Z., Permana, Aiko Z., Norahmawati, Eviana, Widodo, Edwin, Fakurazi, Sharida, Yoshiyuki Kawamoto, and Endharti, Agustina T.
- Subjects
TEAK ,TRIPLE-negative breast cancer ,CANCER prevention ,MATRIX metalloproteinases ,QUERCETIN - Abstract
The limited treatment options for triple-negative breast cancer are attributed to the absence of hormone receptor and human epidermal growth factor receptor 2 gene expression. There is a growing need to explore novel therapeutic drugs or combination therapies that can enhance the efficacy of Triple Negative Breast Cancer. Tectona grandis, with its antioxidant properties and potential health benefits, holds promise in cancer prevention and therapy. The objective of this research is to evaluate the potential of the bioactive substances of T. grandis as cancer drugs. The matrix metalloproteinase-9 structure was obtained from Protein Data Bank, while the substances derived from T. grandis were sourced from various existing studies and screened using PASS database, Lipinski's rule of five, and Veber rule. The molecular docking was performed using PyRx and visualized using PyMOL. ProteinsPlus and LigPlus were used to visualize the interaction between protein and ligand in a diagram. Twelve active substances of T. grandis leaves (butyl acetate, 4-hydroxy-4-methyl-2-pentanone, glycerin monoacetate, glycerin diacetate, methyl decanoate, sinapic acid, gallic acid, ferulic acid, P-coumarate, cinnamic acid, vanillic acid, and quercetin) show potential as anticancer agents based on PASS screening from Lipinski's rule of five and Veber rule. Among these, quercetin (-10), gallic acid (-7.3), and ferulic acid (-7.3) demonstrate the lowest binding energies according to molecular docking. Notably, quercetin exhibits the most favorable activity potential in PASS screening for both anticarcinogenic (0.757/0.007) and antineoplastic especially against breast cancer (0.577/0.012). Quercetin demonstrated the highest potential to work as a Matrix Metalloproteinase-9 inhibitor. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
42. Unveiling a Dermatological Rarity: The Enigma of Vulvar Intraepithelial Neoplasia Grade III (HSIL) and the Role of p53 in Its Development.
- Author
-
Brzeziński, Piotr, Feszak, Igor, Ortiz, Beatriz Di Martino, Feszak, Sylwia, Kawczak, Piotr, and Bączek, Tomasz
- Subjects
CELL nuclei ,VULVAR cancer ,SQUAMOUS cell carcinoma ,CANCER invasiveness ,CANCER prevention ,CERVICAL intraepithelial neoplasia - Abstract
Vulvar intraepithelial neoplasia, also known as VIN, is a non-invasive squamous lesion and precursor of squamous cell carcinoma (SCC) of the vulva. There is no screening test for vulvar intraepithelial neoplasia. Diagnosis of VIN is made clinically and confirmed with a biopsy. We describe a 66-year-old woman with a condyloma-like tumour located in the skin on the vestibule of the vagina. A biopsy sample was taken from the nodule. The definitive diagnosis is supported by the histological examination (VIN III) and immunohistochemical examination of p16(+), p53(+), and a few cell nuclei. The case provides information on the importance of multidisciplinary cooperation. Lifelong surveillance is essential since the resection of individual lesions does not guarantee the prevention of invasive cancer. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
43. Community Health Navigators for Cancer Screening Among Deaf, Deafblind, and Hard of Hearing Adults Who Use American Sign Language.
- Author
-
Bergeron, E., Valdez, R., Moreland, C. J., Wang, R., Knight, T., and Kushalnagar, P.
- Abstract
Deaf, deafblind, and hard of hearing (DDBHH) individuals experience barriers to accessing cancer screening, including ineffective patient-physician communication when discussing screening recommendations. For other underserved communities, culturally and linguistically aligned community health navigators (CHNs) have been shown to improve cancer screening and care. A needs assessment study was conducted to identify barriers and gather recommendations for CHN training resources. A community-based participatory needs assessment was conducted from May 2022 to June 2022 using three focus groups. Eight were cancer survivors, six advocates/navigators, and three clinicians. All questions were semi-structured and covered screening barriers, observations or personal experiences, perceived usefulness of having a CHN to promote cancer screening adherence, and training resources that may be useful to American Sign Language (ASL)–proficient CHNs, who are also culturally and linguistically aligned. Out of 20 focus group participants, seven self-identified as persons of color. Data highlighted systemic, attitudinal, communication, and personal-level barriers as recurrent themes. The most frequently cited barrier was access to training that supports the role and competencies of CHNs, followed by cultural considerations, access to cancer guidelines in ASL, dialect diversity in sign language, and the health system itself. Unaddressed barriers can contribute to health disparities, such as lower preventive cancer screening rates amongst DDBHH individuals. The next step is to translate recommendations into actionable tasks for DDBHH CHN training programs. As a result, CHNs will be well-equipped to help DDBHH individuals navigate and overcome their unique barriers to cancer screening and healthcare access. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
44. Unlocking the Potential: Caloric Restriction, Caloric Restriction Mimetics, and Their Impact on Cancer Prevention and Treatment.
- Author
-
De-Leon-Covarrubias, Ulises Edgardo, Perez-Trujillo, Jose Juan, Villa-Cedillo, Sheila Adela, Martinez-Perez, Alejandra Guadalupe, Montes-de-Oca-Saucedo, Carlos Roberto, Loera-Arias, Maria de Jesus, Garcia-Garcia, Aracely, Saucedo-Cardenas, Odila, and Montes-de-Oca-Luna, Roberto
- Subjects
ANTINEOPLASTIC agents ,FASTING ,CANCER prevention ,DISEASE risk factors ,CLINICAL trials ,LOW-calorie diet ,ASPIRIN ,METFORMIN - Abstract
Caloric restriction (CR) and its related alternatives have been shown to be the only interventions capable of extending lifespan and decreasing the risk of cancer, along with a reduction in burden in pre-clinical trials. Nevertheless, the results from clinical trials have not been as conclusive as the pre-clinical results. Recognizing the challenges associated with long-term fasting, the application of caloric restriction mimetics (CRMs), pharmacological agents that mimic the molecular effects of CR, to harness the potential benefits while overcoming the practical limitations of fasting has resulted in an interesting alternative. This review synthesizes the findings of diverse clinical trials evaluating the safety and efficacy of CR and CRMs. In dietary interventions, a fast-mimicking diet was the most tolerated to reduce tumoral growth markers and chemotherapy side effects. CRMs were well tolerated, and metformin and aspirin showed the most promising effect in reducing cancer risk in a selected group of patients. The application of CR and/or CRMs shows promising effects in anti-cancer therapy; however, there is a need for more evidence to safely include these interventions in standard-of-care therapies. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
45. Building and Maintaining a Whole Community Initiative: Health Communication in Practice with Be Well Communities™.
- Author
-
Love, Brad, Ghosh, Charulata, Kriss, Lauren, Vieco-Garcia, Martha, Fick, Hayley, Shin, Ellen, Wagner, Jessica H., De Luca, Daniela, Dermid, Gerold, McDonald, Lauren, Caballero, Elizabeth, Oestman, Katherine, Coffman, Rosemary, Aquino, Mayra, Adams, Terrence, Gardiner, Haley, and Rechis, Ruth
- Subjects
- *
MEDICAL communication , *HEALTH care teams , *CANCER prevention , *COMMUNITY support , *BEST practices - Abstract
The most effective health communication builds from evidence-based best practices and theory. In practice, health campaigns rely on considerations often under-discussed in health communication, such as consistent agency-style client service, image management, and community coalition-building. Health outcome progress often requires change at multiple levels, from individual cognition and behavior to policy creation. These multi-level needs further highlight the importance of effective practical health communication supporting a range of outcomes and building toward replication. This article covers the complexities of building and implementing a theory-informed health communication structure for a multifaceted, place-based cancer prevention initiative. Part of the overall process includes detailing the internal communications of a health communication group, interorganizational communication, engaging community partner support, the message creation process, and longitudinal efforts on program maintenance and assessment. Furthermore, this article seeks to offer an example of the client service role a health communication team can play to combine theory, empirical message development, and community goals in whole community efforts. Ultimately, the goal is to share experiences from seven years of program work to help guide future community-based efforts in other health contexts and foster progress in theoretical and practical understandings of health communication. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
46. A Mn2+‐Assisted Nanofiber‐Hydrogel Adjuvant for Simultaneous Enhancement of Humoral and Cellular Immune Responses.
- Author
-
Jia, Haixue, Lin, Jia, Wang, Dianyu, Lv, Xue, Wang, Qian, Wang, Zhongyan, Liu, Jinjian, Yang, Lijun, and Liu, Jianfeng
- Subjects
- *
HUMORAL immunity , *GERMINAL centers , *IMMUNE response , *CANCER prevention , *IMMUNOREGULATION , *B cells - Abstract
Limited ability to elicit cellular immune responses has restricted the effectiveness of conventional adjuvants in the context of cancers. Recent advancements in innate immune activation mechanism investigations have paved the way for the implementation of a "bottom‐up" approach in the development of novel adjuvants. Herein, a simple hydrogel adjuvant with a uniformly organized nanoscale microstructure, termed MnPgel is devised, by employing self‐assembling peptides incorporated with manganese ions (Mn2+). MnPgel exhibits Mn2+ sustained‐release properties in vivo and effectively promotes germinal center formation, thereby facilitating the generation of antibodies at levels comparable to conventional aluminum‐based adjuvants. Moreover, MnPgel transcends the scope of humoral immunity, demonstrating the ability to robustly trigger cellular immune responses and positioning it as a promising candidate for cancer prevention and treatments. In conclusion, the work has introduced a well‐defined hydrogel adjuvant as a proof‐of‐concept, simplifying vaccine adjuvant design and opening up new avenues for "on‐demand" immunomodulation strategies. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
47. Aspirin in Primary Prevention: Looking for Those Who Enjoy It.
- Author
-
Della Bona, Roberta, Giubilato, Simona, Palmieri, Marco, Benenati, Stefano, Rossini, Roberta, Di Fusco, Stefania Angela, Novarese, Filippo, Mascia, Giuseppe, Gasparetto, Nicola, Di Monaco, Antonio, Gatto, Laura, Zilio, Filippo, Sorini Dini, Carlotta, Borrello, Francesco, Geraci, Giovanna, Riccio, Carmine, De Luca, Leonardo, Colivicchi, Furio, Grimaldi, Massimo, and Giulizia, Michele Massimo
- Subjects
- *
ANTILIPEMIC agents , *ASPIRIN , *CANCER prevention , *CARDIOVASCULAR diseases risk factors , *DISEASE risk factors - Abstract
Based on a wealth of evidence, aspirin is one of the cornerstones of secondary prevention of cardiovascular disease. However, despite several studies showing efficacy also in primary prevention, an unopposed excess risk of bleeding leading to a very thin safety margin is evident in subjects without a clear acute cardiovascular event. Overall, the variability in recommendations from different scientific societies for aspirin use in primary prevention is a classic example of failure of simple risk stratification models based on competing risks (atherothrombosis vs. bleeding), perceived to be opposed but intertwined at the pathophysiological level. Notably, cardiovascular risk is dynamic in nature and cannot be accurately captured by scores, which do not always consider risk enhancers. Furthermore, the widespread use of other potent medications in primary prevention, such as lipid-lowering and anti-hypertensive drugs, might be reducing the benefit of aspirin in recent trials. Some authors, drawing from specific pathophysiological data, have suggested that specific subgroups might benefit more from aspirin. This includes patients with diabetes and those with obesity; sex-based differences are considered as well. Moreover, molecular analysis of platelet reactivity has been proposed. A beneficial effect of aspirin has also been demonstrated for the prevention of cancer, especially colorectal. This review explores evidence and controversies concerning the use of aspirin in primary prevention, considering new perspectives in order to provide a comprehensive individualized approach. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
48. Germline BARD1 variants predispose to mesothelioma by impairing DNA repair and calcium signaling.
- Author
-
Novelli, Flavia, Yoshikawa, Yoshie, Maria Vitto, Veronica Angela, Modesti, Lorenzo, Minaai, Michael, Pastorino, Sandra, Mitsuru Emi, Jin-Hee Kim, Kricek, Franz, Fang Bai, Onuchic, José N., Bononi, Angela, Suarez, Joelle S., Tanji, Mika, Favaron, Cristina, Zolondick, Alicia A., Ronghui Xu, Yasutaka Takanishi, Zhanwei Wang, and Sakamoto, Greg
- Subjects
- *
P53 protein , *DNA repair , *NATURE & nurture , *MISSENSE mutation , *ECOLOGICAL genetics - Abstract
We report that ~1.8% of all mesothelioma patients and 4.9% of those younger than 55, carry rare germline variants of the BRCA1 associated RING domain 1 (BARD1) gene that were predicted to be damaging by computational analyses. We conducted functional assays, essential for accurate interpretation of missense variants, in primary fibroblasts that we established in tissue culture from a patient carrying the heterozygous BARD1V523A mutation. We found that these cells had genomic instability, reduced DNA repair, and impaired apoptosis. Investigating the underlying signaling pathways, we found that BARD1 forms a trimeric protein complex with p53 and SERCA2 that regulates calcium signaling and apoptosis. We validated these findings in BARD1-silenced primary human mesothelial cells exposed to asbestos. Our study elucidated mechanisms of BARD1 activity and revealed that heterozygous germline BARD1 mutations favor the development of mesothelioma and increase the susceptibility to asbestos carcinogenesis. These mesotheliomas are significantly less aggressive compared to mesotheliomas in asbestos workers. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
49. Coffee Bean and Its Chemical Constituent Caffeine and Chlorogenic Acid as Promising Chemoprevention Agents: Updated Biological Studies against Cancer Cells.
- Author
-
Aborziza, Mohamed, Amalia, Riezki, Zuhrotun, Ade, Ikram, Nur Kusaira Khairul, Novitasari, Dhania, and Muchtaridi, Muchtaridi
- Subjects
- *
CHLOROGENIC acid , *COFFEE , *BEVERAGE consumption , *ANTINEOPLASTIC agents , *CANCER prevention - Abstract
Cancer is a complicated and ever-evolving disease that remains a significant global cause of disease and mortality. Its complexity, which is evident at the genetic and phenotypic levels, contributes to its diversity and resistance to treatment. Numerous scientific investigations on human and animal models demonstrate the potential of phytochemicals in cancer prevention. Coffee has been shown to possess potent anti-carcinogenic properties, and studies have documented the consumption of coffee as a beverage reduces the risk of cancer occurrence. The major secondary metabolites of coffee, named caffeine and chlorogenic acid, have been linked to anti-inflammatory and antineoplastic effects through various signaling. In light of this, this review article provides a comprehensive analysis based on studies in anticancer effects of coffee, chlorogenic acid, and caffeine published between 2010 and 2023, sourced from Scopus, Pubmed, and Google Scholar databases. We summarize recent advances and scientific evidence on the association of phytochemicals found in coffee with a special emphasis on their biological activities against cancer and their molecular mechanism deemed potential to be used as a novel therapeutic target for cancer prevention and therapy. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
50. Genetic Testing Uptake among Ovarian Cancer Survivors in the Genetic Risk Analysis in Ovarian Cancer (GRACE) Study.
- Author
-
White, Larissa L., Sawyer, Jennifer K., Zepp, Jamilyn M., Prado, Yolanda K., Reyes, Ana A., Maiyani, Mahesh, Shuster, Elizabeth, Zucker, Rachel, Henrikson, Nora B., Rope, Alan F., Weinmann, Sheila, Feigelson, Heather S., and Ezzell Hunter, Jessica
- Subjects
- *
RISK assessment , *HEALTH services accessibility , *RESEARCH funding , *OVARIAN tumors , *GENETIC counseling , *EXPERIMENTAL design , *GENETIC disorders , *HEALTH behavior , *CANCER patient psychology , *GENETIC testing , *MEDICAL referrals , *SEQUENCE analysis , *DISEASE risk factors - Abstract
Simple Summary: The improvement in genetic testing uptake for ovarian cancer faces barriers, such as deficiency in access to genetic testing and counseling, lack of referral, and poor follow-up to completion. Genetic risk information can be utilized to guide risk reduction strategies and management during ovarian cancer treatment. The Genetic Risk Analysis in ovarian CancEr (GRACE) study aimed to evaluate the feasibility of retrospective identification ("Traceback") of both individuals diagnosed with ovarian cancer and their families who could benefit from genetic risk information. The GRACE study findings can assist health care systems to implement and increase genetic testing for survivors of ovarian cancer and other hereditary cancers. Background: Recommendations state all people with ovarian cancers (OCs) receive genetic counseling, but testing uptake is only between 15 and 31%. Those with a prior diagnosis of OC who have not received genetic testing represent a missed opportunity for life-saving genetic risk information. The Genetic Risk Analysis in ovarian CancEr (GRACE) study aimed to evaluate the feasibility of the retrospective identification ("Traceback") of individuals diagnosed with OC. Methods: This nonrandomized intervention study within two integrated health care systems identified participants with a history of OC between 1998 and 2020 who did not have genetic testing or testing limited to BRCA1/2. Participants received clinical genomic sequencing via a custom 60 gene panel. This study measured the feasibility of the Traceback methodology in OC survivors. Results: The initial cohort included 929 individuals, of which 57% had no prior genetic testing. Of the 302 eligible for recruitment, 88 consented to participate. We were able to outreach 97% of the eligible population using contact information from medical records. The stage at diagnosis was the only factor associated with consent. Of the 78 who returned their saliva sample, 21% had pathogenic/likely pathogenic variants, and 79% had negative results. Conclusion: The GRACE study resulted in a 29% uptake of genetic testing in OC survivors. The time since diagnosis did not have an impact on consent or ability to contact. GRACE can inform the implementation of future Traceback programs, providing guidance on how to prevent and mitigate the burden of OC and other hereditary cancers. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.